MedMira Inc.
MIR.V
TSX
Weiss Ratings | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Very Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Weak | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.04 | |||
Price History | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 4.76% | |||
30-Day Total Return | -15.38% | |||
60-Day Total Return | 29.41% | |||
90-Day Total Return | 22.22% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | 22.22% | |||
2-Year Total Return | -15.38% | |||
3-Year Total Return | -8.33% | |||
5-Year Total Return | 450.00% | |||
52-Week High % Change | -28.57% | |||
52-Week Low % Change | 42.86% | |||
Price | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.14 | |||
52-Week Low Price | $0.07 | |||
52-Week Low Price (Date) | Apr 19, 2024 | |||
52-Week High Price (Date) | Jan 27, 2025 | |||
Valuation | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 48.79M | |||
Enterprise Value | 58.87M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | 0.00 | |||
Earnings Per Share Growth | 21.62% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 333.33 | |||
Price/Book (Q) | -5.05 | |||
Enterprise Value/Revenue (TTM) | 224.25 | |||
Price | $0.11 | |||
Enterprise Value/EBITDA (TTM) | -28.33 | |||
Enterprise Value/EBIT | -26.43 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 701.73M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 902 450 1588 | |||
Address | 155 Chain Lake Drive Halifax, NS B3S 1B3 | |||
Website | medmira.com | |||
Country | Canada | |||
Year Founded | 1993 | |||
Profitability | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -848.30% | |||
Profit Margin | -1,075.46% | |||
Management Effectiveness | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -40.43% | |||
Return on Equity | -- | |||
Income Statement | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 262.50K | |||
Total Revenue (TTM) | 262.50K | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | -486.70K | |||
EBITDA (TTM) | -2.08M | |||
EBIT (TTM) | -2.23M | |||
Net Income (TTM) | -2.82M | |||
Net Income Avl. to Common (TTM) | -2.82M | |||
Total Revenue Growth (Q YOY) | -47.93% | |||
Earnings Growth (Q YOY) | -65.77% | |||
EPS Diluted (TTM) | 0.00 | |||
EPS Diluted Growth (Q YOY) | -87.50% | |||
Balance Sheet | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 757.50K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 1.92M | |||
Total Preferred Equity (Q) | 0.00 | |||
Total Equity (Q) | -13.88M | |||
Current Ratio (Q) | 0.125 | |||
Book Value Per Share (Q) | -$0.02 | |||
Total Assets (Q) | 3.58M | |||
Total Current Liabilities (Q) | 15.32M | |||
Total Debt (Q) | 11.16M | |||
Total Liabilities (Q) | 17.46M | |||
Total Common Equity (Q) | -13.88M | |||
Cash Flow | MIR.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -543.20K | |||
Cash from Financing (TTM) | 3.06M | |||
Net Change in Cash (TTM) | 130.60K | |||
Levered Free Cash Flow (TTM) | -3.75M | |||
Cash from Operations (TTM) | -2.39M | |||